saaf

PODD

INSULET CORP

Compliant
Sector
Healthcare
Industry
Medical Devices
Score
89/100
Data as of
2026-02-18
Figures are read automatically from SEC filings — tap any number to verify the source.
How is this score computed?

The score has two parts. The verdict sets the base — Compliant starts at 50. Then up to 50 more is added for headroom: the further a company's ratios sit below their limits, the higher it climbs. Barely clearing the limits lands near 50; plenty of room to spare approaches 100.

PODD's ratios average 78.14% of headroom below their limits, so it scores 89 (50 base + 39 for headroom).

Price

Screening standard

How the verdict was computed

  • Business activity

    Business activity is compliant.

  • Debt vs. market cap8.01% vs limit 33.00%

    interest-bearing debt / market cap = 8.01% (< 33% limit).

  • Interest income vs. revenue1.28% vs limit 5.00%

    interest income / total revenue = 1.28% (< 5% limit).

  • Cash & interest-bearing assets vs. market cap5.18% vs limit 33.00%

    (cash + interest-bearing securities) / market cap = 5.18% (< 33% limit).

Every number, sourced

Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.

FigureValue (as filed)FilingSource
Total revenueRevenues$2.7B10-K · 2026-02-18View filing ↗
Interest-bearing debtLong term debt$1.4B10-K · 2023-02-24View filing ↗
Cash & interest-bearing securitiesCash and cash equivalents at carrying value$907.2M10-K · 2021-02-24View filing ↗
Interest incomeInvestment income interest$34.7M10-K · 2026-02-18View filing ↗
Total assetsAssets$3.2B10-K · 2026-02-18View filing ↗
ReceivablesAccounts receivable net current$140.9M10-K · 2023-02-24View filing ↗
Shares outstandingEntity common stock shares outstanding69.3M shares10-Q · 2026-05-06View filing ↗
Priceyahoo:24mo-trailing-avg$252.769market

Values & Controversies

Separate from the shariah verdict above — always.

No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we track.